SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hemo Organic Ltd (524590) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 524590 NSE: | Trading | Small Cap

Hemo Organic Share Price

11.90 -0.62 (-4.95%)
As on 10-Apr'26 16:59

Hemo Organic Ltd (524590)

BSE: 524590 NSE:
Key Metrics
Market Cap
₹4 Cr.
P/E Ratio
40.44
Price to Book (P/B)
-9.76
Price to Sales (P/S)
1.71
EV/EBITDA
164.70
Return on Capital Employed (ROCE)
2.51%
Current Price
₹11.9
Return on Equity (ROE)
0.00%
Return on Assets (ROA)
5.83%
Operating Profit Margin
-1.7%
Net Profit Margin
6.79%
Gross Profit Margin
1.1%
Book Value per Share
₹-1.2
Sales Growth (YoY)
11950%
Sales Growth (3 Years)
522.31%
Operating Profit Growth (1 Year)
NA%
Operating Profit Growth (3 Years)
N/A%
Net Profit Growth (1 Year)
NA%
52-Week Low / High
₹8 / 23
Net Profit Growth (3 Years)
N/A%
Dividend Yield
0.00%
Promoter Holding
16.85%
Pledged shares (%)
of Promoter's holding (%)
0.00%

Check Before You Invest

Q.1
Hemo Organic Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.1 Gross Profit margin of Hemo Organic Ltd?
Hemo Organic Ltd Gross profit margin which is the profit after deduction of direct costs, is 1.1% for FY-2025 , which is above its 5 year median of 0% , indicating increasing margins.
Q.1 Promoter shareholding and pledge status of Hemo Organic Ltd?
Promoters hold 16.85% of the Hemo Organic Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Revenue growth of Hemo Organic Ltd vs industry peers?
Hemo Organic Ltd revenue CAGR is 53.81% , compared to the industry median CAGR of 17.75% , indicating faster growth and gaining its market share.
Q.1 Stock return of Hemo Organic Ltd over the last decade?
Over the last 9 years, the stock has delivered a CAGR of -3.5% based on the current price.
Q.1 Is Hemo Organic Ltd a good quality company?
Hemo Organic Ltd is a quality company, based on a 10 year financial track record .

DeciZen - make an informed investing decision on Hemo Organic

Based on:

M-Cap below 100cr DeciZen not available

Hemo Organic stock performance

Key Ratios
mw4me loader

Is Hemo Organic Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Hemo Organic Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -96.6%-19.2%-39.9%-43.1%-11.4%-44.1%-89.3%-484.9%-53.8%2.5%-
Value Creation
Index
-7.9-2.4-3.9-4.1-1.8-4.2-7.4NANA-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.10.60.10.10.300002.42
Sales YoY Gr.-445.5%-85%-44.4%460%-96.4%0%-100%NA11,950%-
Adj EPS -0.9-0.2-0.4-0.4-0.1-0.1-0.2-0.2-0.80.50.3
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 1.21.20.70.40.30.20-0.2-0.9-0.4-1.2
Adj Net
Profit
-0.3-0.1-0.2-0.1-0-0.1-0.1-0.1-0.30.20
Cash Flow from Ops. -0.8-0.2-0.1-00-0-00.1-1.2-0.4-
Debt/CF from Ops. 00-0.7-20.3-2.6-7.90.3-1-4.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 40.9%53.8%522.3%11950%
Adj EPS NANANANA
BVPS-189.2%-205.9%-453%NA
Share Price -3.5% -3.9% 4.5% 19.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-39.5-19.2-44.9-61.4-17.5-53.4-180.2228.6144.2-70.2-34.9
Op. Profit
Mgn %
-50.2-13.1-170.4-219.7-6.8-591.5-910.7-1135.4-1089.3-1.76
Net Profit
Mgn %
-294.8-13.1-170.3-219.7-7.9-593.2-913.2-1137.5-1179.66.84.2
Debt to
Equity
000.30.600.510.2-0.7-3.9-9.8-
Working Cap
Days
8813683,6225,3975703,4904,3956,5597,15541444
Cash Conv.
Cycle
251611,0021,569-1332,4103,301031511610

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 0.3 -
TTM Sales (₹ Cr.) 2.4 -
BVPS (₹) -1.2 -
Reserves (₹ Cr.) -4 -
P/BV -9.76 -
PE 40.44 -
From the Market
52 Week Low / High (₹) 8.08 / 22.51
All Time Low / High (₹) 0.50 / 140.40
Market Cap (₹ Cr.) 4.1
Equity (₹ Cr.) 3.5
Face Value (₹) 10
Industry PE 24.2

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Hemo Organic - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0.110.600.090.050.280.010.0100.022.41
Operating Expenses + 0.170.680.230.170.300.060.070.060.272.46
Manufacturing Costs0000000000
Material Costs0.070.530.080.070.1900.0100.022.20
Employee Cost 0.050.030.020.010.010.010.01000.03
Other Costs 0.050.120.140.090.090.040.050.060.250.23
Operating Profit -0.06-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.24-0.04
Operating Profit Margin (%) -50.2%-13.1%-170.0%-219.0%-6.8%-591.0%-910.0%-1,135.4%-1,089.3%-1.7%
Other Income + 0000000000.07
Exceptional Items -0.71000000000
Interest 000000000.020
Depreciation 0.06000000000
Profit Before Tax -0.82-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.260.03
Tax 000000000-0.14
Profit After Tax -0.82-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.260.16
PAT Margin (%) -741.0%-13.1%-170.0%-219.0%-7.9%-593.0%-913.0%-1,137.5%-1,179.0%6.8%
Adjusted EPS (₹)-2.4-0.2-0.4-0.4-0.1-0.1-0.2-0.2-0.80.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 0.420.400.260.140.110.070-0.05-0.32-0.15
Share Capital 3.403.473.473.473.473.473.473.473.473.47
Reserves -2.98-3.06-3.21-3.33-3.35-3.40-3.46-3.52-3.78-3.62
Debt +000.080.0800.040.040.041.241.48
Long Term Debt000.080.0800.040.040.041.241.48
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables00.570.660.730.100.080.110.110.113.63
Others Liabilities -0.020.02-0.14-0.14-0.11-0.09-0.050.11-0.10-0.26
Total Liabilities 0.400.990.860.810.110.090.100.200.924.70

Fixed Assets

Net Fixed Assets +0000000000
Gross Block0000000000
Accumulated Depreciation0000000000
CWIP 0000000000
Investments 0000000000
Inventories00.030.020000.020.0201.42
Trade Receivables00.720.720.740.070.070.060.060.082.52
Cash Equivalents 0.080.090.030.020.030.010.010.120.130.01
Others Assets 0.310.140.080.050.010.010.010.010.710.75
Total Assets 0.400.990.860.810.110.090.100.200.924.70

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -0.78-0.15-0.12-0.040.01-0.01-00.11-1.19-0.36
PBT -0.82-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.260.03
Adjustment 0.21000000000
Changes in Working Capital -0.17-0.070.030.080.030.030.060.16-0.93-0.39
Tax Paid 0000000000
Cash Flow From Investing Activity + 0.700.020.060.04000000
Capex 0.70000000000
Net Investments 0000000000
Others -00.020.060.04000000
Cash Flow From Financing Activity + 0.080.150000001.200.24
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 00.0800000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0.080.070000001.200.24
Net Cash Flow -00.01-0.06-0.010.01-0.01-00.110.01-0.12

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-99.33-19.17-44.9-61.38-17.52-53.35N/AN/AN/AN/A
ROCE (%)-96.61-19.17-39.88-43.09-11.35-44.09N/AN/AN/AN/A
Asset Turnover Ratio0.140.860.090.070.60.080.070.030.040.86
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/A-2.25
Working Capital Days
Receivable Days04423,0404,8775303,0683,3714,5011,156197
Inventory Days018114882835131,2240214
Payable Days41972,8513,6087937,2873,74802,538310

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hemo Organic Ltd FAQs

The current trading price of Hemo Organic on 10-Apr-2026 16:59 is ₹11.90.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Apr-2026 the market cap of Hemo Organic stood at ₹4.12 Cr

The latest P/E ratio of Hemo Organic as of 09-Apr-2026 is 40.44.

The latest P/B ratio of Hemo Organic as of 09-Apr-2026 is -9.76.

The 52-week high of Hemo Organic is ₹22.51 and the 52-week low is ₹8.08.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hemo Organic is ₹2.42 ( Cr.) .

About Hemo Organic Ltd

Dinesh Allorga incorporated as public limited Company in August 1992. It is engaged in production and sale of ayurvedic medicines and chemicals.

The registered office is located at 8-A, Gulnar Chinar-Gulnar Apartment, V V Nagar Road, Anand, Gujrat - 388001.

The company has posted net profit of Rs 0.04 crore during the quarter ended June 2011 against the break-even during quarter ended June 2010.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×